Thomas Marbury
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Nephrology top 0.5%
- Acute Kidney Injury Research
Papers in
- Hepatology 35
- Hepatitis C virus research 31
- Co-authors
- Steven G. Chrysant (5 shared papers)Suzanne K. Swan (15 shared papers)Lawrence S. Weisberg (2 shared papers)Robin L. Allgren (2 shared papers)William B. Smith (15 shared papers)Eric Lawitz (20 shared papers)Poul Strange (4 shared papers)Joel Neutel (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (42 papers)Antimicrobial Agents and Chemotherapy (12 papers)Clinical Pharmacokinetics (12 papers)British Journal of Clinical Pharmacology (10 papers)Journal of Hepatology (10 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Thomas Marbury
216 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 128
- Hepatology 783
- Nephrology 721
- Virology 290
- Internal Medicine 191
- Endocrinology, Diabetes and Metabolism 928
Countries citing papers authored by Thomas Marbury
This map shows the geographic impact of Thomas Marbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Marbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Marbury more than expected).
Fields of papers citing papers by Thomas Marbury
This network shows the impact of papers produced by Thomas Marbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Marbury. The network helps show where Thomas Marbury may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Marbury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 328 | |
| 2 | 2001 | 225 | |
| 3 | 2015 | 219 | |
| 4 | 2000 | 171 | |
| 5 | 2015 | 171 | |
| 6 | 2007 | 161 | |
| 7 | 2005 | 150 | |
| 8 | 2010 | 146 | |
| 9 | 1999 | 143 | |
| 10 | 2009 | 135 | |
| 11 | 2012 | 130 | |
| 12 | 2002 | 118 | |
| 13 | 2008 | 115 | |
| 14 | 2015 | 104 | |
| 15 | 1984 | 102 | |
| 16 | 2017 | 99 | |
| 17 | 2000 | 96 | |
| 18 | 1998 | 81 | |
| 19 | 1999 | 80 | |
| 20 | 2012 | 78 |
About Thomas Marbury
Thomas Marbury is a scholar working on Hepatology, Molecular Biology, Pharmacology, Infectious Diseases and Epidemiology, having authored 218 papers that have together received 6.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (31 papers), HIV/AIDS drug development and treatment (19 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers), Pharmacological Effects and Toxicity Studies (17 papers), Blood Pressure and Hypertension Studies (15 papers), Chronic Lymphocytic Leukemia Research (15 papers), Epilepsy research and treatment (11 papers) and Dialysis and Renal Disease Management (10 papers). The work is most often cited by research in Hepatology (783 citations), Nephrology (721 citations), Virology (290 citations), Internal Medicine (191 citations) and Endocrinology, Diabetes and Metabolism (928 citations). Thomas Marbury has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Steven G. Chrysant, Suzanne K. Swan, Lawrence S. Weisberg, Robin L. Allgren, William B. Smith, Eric Lawitz, Poul Strange, Joel Neutel, Kenneth C. Lasseter and Harold E. Lebovitz. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Pharmacokinetics, British Journal of Clinical Pharmacology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.